| | | | | | | | | | | | | | | | | | | | | | |
Ownership Document
|
| Schema Version: X0306 |
| Document Type: 4 |
| Period of Report: 8/14/22 |
| Not Subject to Section 16: 0 |
| Issuer: |
| Issuer CIK: 1337553 |
| Issuer Name: AERIE PHARMACEUTICALS INC |
| Issuer Trading Symbol: AERI |
| Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1732197 |
| | Owner Name: LaRocca John |
| Reporting Owner Address: |
| | Owner Street 1: C/O AERIE PHARMACEUTICALS, INC. |
| | Owner Street 2: 4301 EMPEROR BLVD., SUITE 400 |
| | Owner City: DURHAM |
| | Owner State: NC |
| | Owner ZIP Code: 27703 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? No |
| | Is Officer? Yes |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| | Officer Title: General Counsel |
| Non-Derivative Table: |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Stock |
| | Transaction Date: |
| | | Value: 8/14/22 |
| | Deemed Execution Date: |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: F |
| | | Equity Swap Involved? No |
| | Transaction Timeliness: |
| | | Value: |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 771 |
| Footnote ID: F1 |
| | | Transaction Price Per Share: |
| Value: 11.57 |
| | | Transaction Acquired-Disposed Code: |
| Value: D |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 53,585 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Footnotes: |
| Footnote - F1: Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted Common Stock. |
| Remarks: |
| Owner Signature: |
| Signature Name: /s/ John W. LaRocca |
| Signature Date: 8/16/22 |
